![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 17671-17676, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
, and
§¶
From the Departments of The yeast PDR5 gene encodes an efflux
pump that confers multidrug resistance. Expression of PDR5
is positively regulated by the transcription factors Pdr1p and Pdr3p
that recognize the same pleiotropic drug resistance elements (PDREs) in
the PDR5 promoter. Pdr1p and Pdr3p belong to the Gal4p
family of zinc cluster proteins. The function of RDR1
(YOR380W), which also encodes a member of this family, is
unknown. To identify target genes for Rdr1p, we have performed
whole-genome analysis of gene expression with DNA microarrays. Our
results show that Rdr1p is a transcriptional repressor of five genes,
including PDR5. A
Medicine,
¶ Biochemistry, and § Microbiology and
Immunology, McGill University Health Centre, Royal Victoria Hospital,
McGill University, 687 Pine Ave. West, Montréal, Québec H3A
1A1, Canada
rdr1 strain has increased resistance to cycloheximide, as expected from the overexpression of
PDR5. In addition, the activity of a PDR5-lacZ reporter is increased in a
rdr1 strain. All (but one) genes affected by removal of Rdr1p contain PDREs in their promoters. We tested if the effect of
Rdr1p is mediated through PDREs by inserting this DNA element in front
of a minimal promoter. Activity of this reporter was increased in a
rdr1 strain. Moreover, mutations known to reduce binding
of Pdr1/Pdr3p abolished the induction observed in the
rdr1 strain.
Thus, we have identified a transcriptional repressor involved in the
control of multidrug resistance.
A scholar from the Fonds de la Recherche en Santé du
Québec. To whom correspondence should be addressed. Tel.:
514-842-1231 (ext. 35046); Fax: 514-982-0893; E-mail:
turcotte@lan1.molonc.mcgill.ca.
This article has been cited by other articles:
![]() |
V. Fardeau, G. Lelandais, A. Oldfield, H. Salin, S. Lemoine, M. Garcia, V. Tanty, S. Le Crom, C. Jacq, and F. Devaux The Central Role of PDR1 in the Foundation of Yeast Drug Resistance J. Biol. Chem., February 16, 2007; 282(7): 5063 - 5074. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacPherson, M. Larochelle, and B. Turcotte A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 583 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacPherson, B. Akache, S. Weber, X. De Deken, M. Raymond, and B. Turcotte Candida albicans Zinc Cluster Protein Upc2p Confers Resistance to Antifungal Drugs and Is an Activator of Ergosterol Biosynthetic Genes Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1745 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gao, L. Wang, E. Milgrom, and W.-C. W. Shen On the Mechanism of Constitutive Pdr1 Activator-mediated PDR5 Transcription in Saccharomyces cerevisiae: EVIDENCE FOR ENHANCED RECRUITMENT OF COACTIVATORS AND ALTERED NUCLEOSOME STRUCTURES J. Biol. Chem., October 8, 2004; 279(41): 42677 - 42686. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Akache, S. MacPherson, M.-A. Sylvain, and B. Turcotte Complex Interplay Among Regulators of Drug Resistance Genes in Saccharomyces cerevisiae J. Biol. Chem., July 2, 2004; 279(27): 27855 - 27860. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |